Samsung Biologics has been included in the Dow Jones Best-in-Class World Index for the fifth consecutive year, reflecting its strong commitment to environmental, social, and governance (ESG) practices. The recognition is based on a rigorous global sustainability assessment and highlights the company's improvements in supply chain management, environmental care, and workplace safety. This continued inclusion underscores Samsung Biologics' proactive approach to sustainable growth and transparent governance, supported by recent accolades like an EcoVadis Platinum rating and a sustainability award. The company plans to keep advancing its ESG initiatives while expanding its global manufacturing capacity to support future therapies.
The IBIT Bitcoin ETF, managed by BlackRock, recorded a $292 million net inflow last week, reversing eight consecutive weeks of outflows. This inflow reflects renewed institutional interest in Bitcoin, which currently trades near $70,000. Market confi...
After a 72% price drop, XRP has reached extreme bearish sentiment, with heavy short interest and negative funding rates on Binance. Analysts like Crypto Patel see this as a contrarian buy signal, noting past rebounds of over 100% after similar condit...
Bitcoin is approaching the lower support line of a power-law price model Fidelity has tracked since 2015, currently near $58,000. This line has historically marked major bottoms, suggesting Bitcoin is entering an accumulation zone. However, Fidelity'...
Jurrien Timmer, Fidelity's global macro director, suggests Bitcoin may have reached a critical support level around $60,000, indicating it could be in an accumulation zone. This assessment is based on a power law model that historically marks buying ...
Mark Lanier won a landmark $6 million verdict against Meta and Google, proving their platforms were designed to be addictive and harmful to children's mental health. The case, led by a young plaintiff named Kaley, exposed internal documents showing d...
